Konarska-Bajda, K.; Ceranowicz, P.; Cieszkowski, J.; Ginter, G.; Chmura, A.; Stempniewicz, A.; Gałązka, K.; Kuśnierz-Cabala, B.; Dumnicka, P.; Bonior, J.; Warzecha, Z. Healing Effect of Warfarin in the Course of Cerulein-Induced Acute Pancreatitis. Preprints2023, 2023040658. https://doi.org/10.20944/preprints202304.0658.v1
APA Style
Konarska-Bajda, K., Ceranowicz, P., Cieszkowski, J., Ginter, G., Chmura, A., Stempniewicz, A., Gałązka, K., Kuśnierz-Cabala, B., Dumnicka, P., Bonior, J., & Warzecha, Z. (2023). Healing Effect of Warfarin in the Course of Cerulein-Induced Acute Pancreatitis. Preprints. https://doi.org/10.20944/preprints202304.0658.v1
Chicago/Turabian Style
Konarska-Bajda, K., Joanna Bonior and Zygmunt Warzecha. 2023 "Healing Effect of Warfarin in the Course of Cerulein-Induced Acute Pancreatitis" Preprints. https://doi.org/10.20944/preprints202304.0658.v1
Abstract
Acute pancreatitis (AP) is the most common gastrointestinal disease leading to hospitalizations. The development of AP leads to damage of the pancreatic microcirculation with a cascade of subsequent events resulting, among others, in coagulopathy. Previous research showed that anticoagulants can be an important therapeutic agent. Heparin and acenocoumarol can alleviate the course of AP, as well as accelerate healing and post-inflammatory regeneration of the pancreas. The aim of this study was to check whether warfarin, a drug with more stable effects than acenocoumarol, affects the healing and regeneration of the pancreas in the cerulein-induced AP. AP was evoked in Wistar male rats by intraperitoneal administration of cerulein. The first dose of warfarin (45, 90 or 180 µg/kg/dose) was administered 24 hours after the first dose of cerulein and the doses of warfarin were repeated once a day in subsequent 10 days. The severity of acute pancreatitis was assessed immediately after the last dose of cerulein, as well as 1, 2, 3, 5, and 10 days after AP induction. Treatment with warfarin dose-dependently increased interna-tional normalized ratio (INR) and attenuated the severity of pancreatitis in histological ex-amination and accelerated pancreatic recovery. Those effects were accompanied with a faster reduction in the pancreatitis-evoked increase in serum activity of amylase and lipase, serum concentration of pro-inflammatory interleukin-1β, and plasma level of D-Dimer. In addition, treatment with warfarin decreased pancreatic weight and improved pancreatic blood flow in rats with AP. The therapeutic effect was particularly pronounced after the administration of warfarin at a dose of 90 µg/kg/dose. Conclusion: Administration of warfarin accelerates re-generation of the pancreas and recovery in the course of cerulein-induced mild-edematous acute pancreatitis.
Medicine and Pharmacology, Gastroenterology and Hepatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.